Scarica l'app Stockscreener
25.56
3.46%
-0.86
Precedente Chiudi:
$26.42
Aprire:
$26.05
Volume 24 ore:
146.36K
Relative Volume:
0.04
Capitalizzazione di mercato:
$2.05B
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-11.89
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
-6.02%
1M Prestazione:
-7.82%
6M Prestazione:
+447.32%
1 anno Prestazione:
+335.98%
Intervallo 1D:
$25.20
$26.18
Intervallo di 1 settimana:
$25.20
$27.86
Portata 52W:
$2.86
$36.26
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
25.55 | 2.12B | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.70 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.10 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
825.48 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.46 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
340.86 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Iniziato | Piper Sandler | Overweight |
| 2025-10-08 | Iniziato | Guggenheim | Buy |
| 2025-08-12 | Reiterato | Citigroup | Buy |
| 2024-04-02 | Iniziato | Goldman | Buy |
| 2024-01-30 | Iniziato | Citigroup | Buy |
| 2023-07-21 | Iniziato | Oppenheimer | Outperform |
| 2023-05-05 | Iniziato | CapitalOne | Overweight |
| 2023-02-22 | Iniziato | Credit Suisse | Outperform |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
| 2021-12-07 | Ripresa | Cowen | Outperform |
| 2020-12-14 | Iniziato | Canaccord Genuity | Buy |
| 2020-12-14 | Iniziato | Cowen | Outperform |
| 2020-12-14 | Iniziato | JP Morgan | Overweight |
| 2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 10,000 Shares - MarketBeat
Harmon Cyrus, director at Olema, sells $268,800 in stock - Investing.com
Harmon Cyrus, director at Olema, sells $268,800 in stock By Investing.com - Investing.com South Africa
Does US Foods Holding Corp stock benefit from AI growthPortfolio Return Summary & Real-Time Market Trend Scan - baoquankhu1.vn
Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 3,489 Shares - MarketBeat
A Look At Olema Pharmaceuticals (OLMA) Valuation After Fresh Bullish Analyst Coverage And Conference Spotlight - Sahm
Olema Pharmaceuticals director Harmon sells $101k in stock By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals director Harmon sells $101k in stock - Investing.com
Insider Sell Alert: Kovacs Shane William Charles Sells Shares of Olema Pharmaceuticals Inc (OLMA) - GuruFocus
Wall Street Remains Bullish on Olema Pharmaceuticals Inc. (OLMA) - Insider Monkey
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Insider Sells 3,822 Shares of Stock - MarketBeat
Olema Pharma CFO Kovacs sells shares worth $2.98 million By Investing.com - Investing.com South Africa
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Insider Sells 100,000 Shares of Stock - MarketBeat
Olema Pharma CFO Kovacs sells shares worth $2.98 million - Investing.com
Olema Pharma ch. discov. Myles sells shares worth $2.97 million By Investing.com - Investing.com Nigeria
David Myles Sells 50,000 Shares of Olema Pharmaceuticals (NASDAQ:OLMA) Stock - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Insider David Myles Sells 10,000 Shares - MarketBeat
Olema Pharma ch. discov. Myles sells shares worth $2.97 million - Investing.com
Stop Loss: Is Olema Pharmaceuticals Inc forming bullish engulfing patternsJuly 2025 Closing Moves & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Will Olema Pharmaceuticals Inc. stock pay special dividendsGlobal Markets & Intraday High Probability Alerts - Bộ Nội Vụ
Aug Rallies: What are analysts price targets for Olema Pharmaceuticals IncJuly 2025 Highlights & Real-Time Volume Surge Alerts - baoquankhu1.vn
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
OLMA stock jumps 10% into JPMorgan week — what to watch for Olema Pharmaceuticals - TechStock²
Assessing Olema Pharmaceuticals (OLMA) Valuation After Analyst Upgrades And Recent Fundraising - Sahm
Olema Pharmaceuticals stock jumps 10% into JPM conference week: what OLMA traders are watching next - TechStock²
How Olema Pharmaceuticals Inc. stock performs during Fed tightening cycles2025 Year in Review & AI Enhanced Market Trend Forecasts - Улправда
Buy Signal: Will Olema Pharmaceuticals Inc. stock gain from government policiesMarket Sentiment Review & Weekly Top Gainers Alerts - Улправда
Cashing In at the Peak: Olema Pharmaceuticals Insiders Sell $8 Million in Stock After 300% Surge - FinancialContent
Olema Insider Sells $8 Million in Shares After 300% Stock Surge - Yahoo Finance
Olema Insider Sells $8 Million in Shares After 300% Stock Surge - The Motley Fool
Olema Pharmaceuticals (NASDAQ:OLMA) Raised to Strong-Buy at UBS Group - MarketBeat
How Bullish Analyst Coverage and New Capital Raise Could Impact Olema Pharmaceuticals (OLMA) Investors - Yahoo Finance
Olema Pharmaceuticals, Inc.Common Stock (NQ: OLMA - FinancialContent
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 8.6%Here's What Happened - MarketBeat
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN
Pfizer collaboration with Olema may spark future bidding waranalyst - MSN
UBS Initiates Coverage on Olema Pharmaceuticals (OLMA) with a 'B - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Coverage Initiated by Analysts at Piper Sandler - MarketBeat
Piper Sandler initiates Olema Pharmaceuticals stock with Overweight rating By Investing.com - Investing.com Canada
UBS initiates Olema Pharmaceuticals stock with Buy rating, $45 target By Investing.com - Investing.com Canada
Olema Oncology (OLMA) Targeted for Growth with $60 Price Objecti - GuruFocus
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sahm
Olema Oncology reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Olema Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Biotech Olema gives 8 new employees long-term stock option deals - Stock Titan
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 2,881 Shares of Stock - MarketBeat
Olema Pharmaceuticals director Harmon sells $82,194 in stock By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.06%
2.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):